Patent · US Active

APKC inhibitors and methods of treating a neurodegenerative disease or disorder

US11865125B2 · kind B2 · utility

0Cited by

0References

18Claims

0Family size

Assignees

University of South Florida · US
United States Government as represented by the Department of Veterans Affairs · US

Inventors

Robert Farese · San Francisco, US
Mini Paliyath Sajan · Wesley Chapel, US
Margaret Genevieve HIGGS · St. Petersburg, US

Key dates

Filing date	Dec 17, 2021
Grant date	Jan 9, 2024
Priority date	—
Expiry date	Dec 17, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/23046
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are formulations effective for and methods of treating or preventing a neurodegenerative disorder in a subject in need thereof that can include administering an amount of an aPKC inhibitor to a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.